Pornichet, France

Chris Planque


Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2012-2014

Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Inventor Chris Planque

Introduction

Chris Planque, an accomplished inventor based in Pornichet, France, has made significant strides in the realm of biomedical innovations. With three patents to his name, Chris has focused his research on the critical area of cancer diagnosis and prognostication, particularly related to the KLK8 gene encoding kallikrein 8.

Latest Patents

Among his latest contributions are two patents that delve into newly discovered alternative transcripts of the KLK8 gene, specifically NT5 and NT6. The sequences for these transcripts are meticulously documented, with NT5 set forth in SEQ ID NO:7 and NT6 in SEQ ID NO:8. These innovative transcripts hold substantial promise for the medical community. Furthermore, Chris has developed a method for the in vitro diagnosis of bronchopulmonary carcinoma, focusing on non-small cell bronchial carcinoma. This method includes detecting major alternative transcripts of the KLK8 gene in biological samples from patients suspected of having this type of cancer. This breakthrough technique aids in prognosticating the survival of affected patients, significantly impacting clinical outcomes.

Career Highlights

Chris Planque's career is distinguished by his work with notable organizations, including Biomerieux, Inc. and Université François Rabelais. His tenure in these institutions highlights his commitment to advancing medical innovations and enhancing diagnostic methods, demonstrating his role as a thought leader in his field.

Collaborations

Throughout his research journey, Chris has collaborated with talented professionals such as Mireille Ainciburu and Yves Courty. These partnerships have not only enriched his work but also fostered an environment of shared knowledge and innovative thinking, important for scientific advancements.

Conclusion

In summary, Chris Planque’s contributions to the field of biomedical innovations, especially concerning the KLK8 gene, are invaluable. Through his patents and collaborative efforts, he thrives as a key figure in the ongoing battle against cancer, emphasizing the importance of research in achieving better diagnostic and prognostic tools for patients. The impact of his work is sure to resonate within the medical community for years to come.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…